Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Korean Patients
Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
This is an open-label, multi-centre single arm trial to investigate long-term safety and
tolerability of degarelix in Korean patients with prostate cancer.